ARCHIVES

What Should NCI Do When Center Directors Leave? Kimes Asks

This article is from The Cancer Letter archive.

Vol. 18 No. 30 | July 24, 1992

Download PDF Visit The Full Archive

Related Articles

NCI To Recompete Smokeless Tobaccos RFA as PA

January 24, 1986

Talactoferrin Second-Line Therapy Increases Survival In Stage IIIB/IV

October 28, 2011

In Brief: Columbia Still In Running As Comprehensive Center In ’78; Illinois Withdraws Application

June 24, 1977

Bristol-Myers Cancer Scientist Award Nominations To Close March 1

February 24, 1978

NCI Plans $175 Million In Program Cuts To Cover Deficit, Fund New Initiatives

November 17, 2006

Coalition Members Urged To Demand Intent Of Congress In Cancer Act Be Recognized

March 13, 1981